BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 8209377)

  • 1. The nephrotoxicity of intravenously administered cadmium-metallothionein: effect of dose, mode of administration, and preexisting renal cadmium burden.
    Vestergaard P; Shaikh ZA
    Toxicol Appl Pharmacol; 1994 Jun; 126(2):240-7. PubMed ID: 8209377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal accumulation of cadmium and nephropathy following long-term administration of cadmium-metallothionein.
    Min KS; Onosaka S; Tanaka K
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):102-9. PubMed ID: 8917681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepancy between the nephrotoxic potencies of cadmium-metallothionein and cadmium chloride and the renal concentration of cadmium in the proximal convoluted tubules.
    Dorian C; Gattone VH; Klaassen CD
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):161-8. PubMed ID: 7839364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotoxicity of repeated injections of cadmium-metallothionein in rats.
    Wang XP; Chan HM; Goyer RA; Cherian MG
    Toxicol Appl Pharmacol; 1993 Mar; 119(1):11-6. PubMed ID: 8470114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats.
    Liu J; Habeebu SS; Liu Y; Klaassen CD
    Toxicol Appl Pharmacol; 1998 Nov; 153(1):48-58. PubMed ID: 9875299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotoxicity of cadmium-metallothionein: protection by zinc and role of glutathione.
    Tang W; Sadovic S; Shaikh ZA
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):276-82. PubMed ID: 9707504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of MT-null mice to chronic CdCl2-induced nephrotoxicity indicates that renal injury is not mediated by the CdMT complex.
    Liu J; Liu Y; Habeebu SS; Klaassen CD
    Toxicol Sci; 1998 Nov; 46(1):197-203. PubMed ID: 9928683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cadmium-Metallothionein nephropathy: relationships between ultrastructural/biochemical alterations and intracellular cadmium binding.
    Squibb KS; Pritchard JB; Fowler BA
    J Pharmacol Exp Ther; 1984 Apr; 229(1):311-21. PubMed ID: 6707945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metallothionein plays less of a protective role in cadmium-metallothionein-induced nephrotoxicity than in cadmium chloride-induced hepatotoxicity.
    Liu J; Liu Y; Michalska AE; Choo KH; Klaassen CD
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1216-23. PubMed ID: 8786554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metallothionein-null and wild-type mice show similar cadmium absorption and tissue distribution following oral cadmium administration.
    Liu Y; Liu J; Klaassen CD
    Toxicol Appl Pharmacol; 2001 Sep; 175(3):253-9. PubMed ID: 11559024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal toxicity of cadmium-metallothionein and enzymuria in rats.
    Suzuki CA; Cherian MG
    J Pharmacol Exp Ther; 1987 Jan; 240(1):314-9. PubMed ID: 2879904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotoxicity in rats following liver transplantation from cadmium-exposed rats.
    Chan HM; Zhu LF; Zhong R; Grant D; Goyer RA; Cherian MG
    Toxicol Appl Pharmacol; 1993 Nov; 123(1):89-96. PubMed ID: 8236266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress as a mechanism of chronic cadmium-induced hepatotoxicity and renal toxicity and protection by antioxidants.
    Shaikh ZA; Vu TT; Zaman K
    Toxicol Appl Pharmacol; 1999 Feb; 154(3):256-63. PubMed ID: 9931285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cortical mitochondrial dysfunction upon cadmium metallothionein administration to Sprague-Dawley rats.
    Tang W; Shaikh ZA
    J Toxicol Environ Health A; 2001 Jun; 63(3):221-35. PubMed ID: 11405417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue distribution of cadmium in rats given minimum amounts of cadmium-polluted rice or cadmium chloride for 8 months.
    Hiratsuka H; Satoh Si; Satoh M; Nishijima M; Katsuki Y; Suzuki J; Nakagawa Ji; Sumiyoshi M; Shibutani M; Mitsumori K; Tanaka-Kagawa T; Ando M
    Toxicol Appl Pharmacol; 1999 Oct; 160(2):183-91. PubMed ID: 10527917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of quercetin on metallothionein, nitric oxide synthases and cyclooxygenase-2 expression on experimental chronic cadmium nephrotoxicity in rats.
    Morales AI; Vicente-Sánchez C; Jerkic M; Santiago JM; Sánchez-González PD; Pérez-Barriocanal F; López-Novoa JM
    Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):128-35. PubMed ID: 16226777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dependence of cadmium-metallothionein nephrotoxicity on glutathione.
    Shaikh ZA; Northup JB; Vestergaard P
    J Toxicol Environ Health A; 1999 Jun; 57(3):211-22. PubMed ID: 10376887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cadmium accumulation and metallothionein concentrations after 4-week dietary exposure to cadmium chloride or cadmium-metallothionein in rats.
    Groten JP; Sinkeldam EJ; Luten JB; van Bladeren PJ
    Toxicol Appl Pharmacol; 1991 Dec; 111(3):504-13. PubMed ID: 1746026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance study for the estimation of glomerular filtration of Cd following the intravenous bolus of CdCl2 and Cd-saturated metallothionein-II in rats.
    Hayashi T; Terui J; Sudo J
    Biol Pharm Bull; 1994 Apr; 17(4):557-8. PubMed ID: 8069271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone pretreatment enhances cellular sensitivity to cadmium despite a marked activation of the metallothionein gene.
    Shimada H; Hochadel JF; Waalkes MP
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):178-85. PubMed ID: 9007047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.